跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Kemocarb - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Kemocarb
Approved
STANDARD
Kemocarb
Fresenius Kabi Oncology Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
4268e5e264a0b542
Company
Fresenius Kabi Oncology Limited
Type
Standard
Approval Details
Approval Id
4268e5e264a0b542
Drug Approval Philippines Name
Kemocarb
Product Name
Kemocarb
Registration Number
DR-XY47196
Brand Name
Kemocarb
Generic Name
Carboplatin
Dosage Form
Solution For IV Infusion
Dosage Strength
10 mg/mL (150 mg/15 mL and 450/45 mL)
Manufacturer
Fresenius Kabi Oncology Limited
Importer
Fresenius Kabi Philippines, Inc.
Company Detail Path
/organization/fresenius-kabi-oncology-limited
Issuance Date
26 January 2023
Expiry Date
18 March 2028
Pharmacologic Category
Antineoplastic
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
4268e5e264a0b542
Type
Standard
Back to Philippines FDA Approvals